
Doxapram Hydrochloride
CAS number: 7081-53-0
Molecular formula: C24H30N2O2.HCl.H2O
molecular weight: 432.99
Chemical structure:
Producers shown on SFDA
(Record date:18/10/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Xi'an Libang Pharmaceutical Co., Ltd. | GMP | Valid till March 2019 |
Jiangsu Nhwa Pharmaceutical Co., Ltd. | GMP | Valid till March 2020 |
Producers shown on EP
(Quoted from EP website;record date:18/10/2021)
Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
Doxapram Hydrochloride | MIDAS PHARMA GMBH Ingelheim am Rhein DE | R0-CEP 2017-084 - Rev 01 | 13/08/2021 | Valid | / | Chemical |
Producer:Xi'an Libang Pharmaceutical Co., Ltd. was founded by returned overseas students in 1996. It is a high-tech enterprise integrating drug R & D, production and sales. The company is located in Xi'an high tech Industrial Development Zone with a registered capital of 15 million yuan. Its three pharmaceutical factories have passed the new GMP certification; It has more than ten GMP production lines such as small volume injection, large volume injection and oral solution; It produces more than 20 kinds of chemical synthetic APIs and more than 50 specifications of pharmaceutical preparations.
Staff size:500-599 persons
Registered capital:RMB 15 million
Producer:Jiangsu Nhwa Pharmaceutical Co., Ltd. founded in 1978 and listed on Shenzhen Stock Exchange in 2008, is a pharmaceutical enterprise integrating science, industry and trade.
It has three large pharmaceutical GMP production bases for APIs and preparations, covering a total area of more than 900 mu. The enterprise has national certified workshops for APIs, solid preparations, water injections and lyophilized powder injections, and more than 10 automatic production lines for tablets, capsules, water injections and powder injections. At present, there are 39 kinds of APIs, 300 tons / year; More than 100 kinds of Western medicine preparations, 4 billion tablets (tablets) of solid preparations per year and 100 million injections per year.
According to the enterprise development strategy, we have made great efforts to save energy, reduce consumption and protect the environment, passed the international environmental certification (ISO14000), vigorously developed the export business of API, carried out EU edmf and FDA certification, and strive to gain a place in the international market.
Staff size:About 5000 persons
Registered capital:RMB 1 billion 8 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978